Evidence map›Paper›PMID 30950397›Full record

ArticleActa crystallographica. Section D, Structural biology2019

Making routine native SAD a reality: lessons from beamline X06DA at the Swiss Light Source.

Shibom Basu, Aaron Finke, Laura Vera, Meitian Wang, Vincent Olieric

Abstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Modeling of Protein Complexes.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Article
  7. Native SAD phasing at room temperature.Acta crystallographica. Section D, Structural biology · 2022
    Article
  8. Article
  9. Article
  10. Current research in structural biology · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shibom BasuSwiss Light Source, Paul Scherrer Institut, Villigen PSI, Switzerland.ORCID 0000-0001-6484-8236
Aaron FinkeMacCHESS, Cornell University, Ithaca, New York, USA.
Laura VeraSwiss Light Source, Paul Scherrer Institut, Villigen PSI, Switzerland.
Meitian WangSwiss Light Source, Paul Scherrer Institut, Villigen PSI, Switzerland.
Vincent OliericSwiss Light Source, Paul Scherrer Institut, Villigen PSI, Switzerland.ORCID 0000-0002-0533-7222

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Native single-wavelength anomalous dispersion (SAD) is the most attractive de novo phasing method in macromolecular crystallography, as it directly utilizes intrinsic anomalous scattering from native crystals. However, the success of such an experiment depends on accurate measurements of the reflection intensities and therefore on careful data-collection protocols. Here, the low-dose, multiple-orientation data-collection protocol for native SAD phasing developed at beamline X06DA (PXIII) at the Swiss Light Source is reviewed, and its usage over the last four years on conventional crystals (>50 µm) is reported. Being experimentally very simple and fast, this method has gained popularity and has delivered 45 de novo structures to date (13 of which have been published). Native SAD is currently the primary choice for experimental phasing among X06DA users. The method can address challenging cases: here, native SAD phasing performed on a streptavidin-biotin crystal with P2

Indexed as

CrystallizationCrystallography, X-RayMacromolecular SubstancesModels, MolecularProtein ConformationStreptavidinMacromolecular SubstancesStreptavidinanomalous signaldata-collection strategydata multiplicitymulti-axis goniometernative SAD phasing

Identifiers

PMID30950397
PMCPMC6450063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.